Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development
Open accessThe DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Innate immune signaling through the NLRP3 inflammasome is activated by multiple diabetes-related stressors, but whether targeting the inflammasome is beneficial for diabetes is still unclear. Nucleoside reverse-transcriptase inhibitors (NRTI), drugs approved to treat HIV-1 and hepatitis B infections, also block inflammasome activation. Here, we show, by analyzing five health insurance databases, that the adjusted risk of incident diabetes is 33% lower in patients with NRTI exposure among 128,861 patients with HIV-1 or hepatitis B (adjusted hazard ratio for NRTI exposure, 0.673; 95% confidence interval, 0.638 to 0.710; P < 0.0001; 95% prediction interval, 0.618 to 0.734). Meanwhile, an NRTI, lamivudine, improves insulin sensitivity and reduces inflammasome activation in diabetic and insulin resistance-induced human cells, as well as in mice fed with high-fat chow; mechanistically, inflammasome-activating short interspersed nuclear element (SINE) transcripts are elevated, whereas SINE-catabolizing DICER1 is reduced, in diabetic cells and mice. These data suggest the possibility of repurposing an approved class of drugs for prevention of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“As an example, epidemiological evidence suggests that NRTIs reduce the incidence of type 2 diabetes112.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [112]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
Gelman, A. (2006) · Bayesian Analysis · doi:10.1214/06-ba117a · Cited by 4,050
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
Cited by
The role of retrotransposable elements in ageing and age-associated diseases
Gorbunova, V., Seluanov, A., Mita, P., McKerrow, W., Fenyö, D., Boeke, J. D., Linker, S. B., Gage, F. H., Kreiling, J. A., Petrashen, A. P., et al. (2021) · Nature · doi:10.1038/s41586-021-03542-y · Cited by 446
Inflammasomes as therapeutic targets in human diseases
Li, Y., Huang, H., Liu, B., Zhang, Y., Pan, X., Yu, X.-Y., Shen, Z., & Song, Y.-H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00650-z · Cited by 223
Approved HIV reverse transcriptase inhibitors in the past decade
Li, G., Wang, Y., & Clercq, E. D. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.009 · Cited by 144
NLRP3 inflammasome and IL-1β pathway in type 2 diabetes and atherosclerosis: Friend or foe?
Chen, X., Zhang, D., Li, Y., Wang, W., Bei, W., & Guo, J. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105885 · Cited by 85
The Immunological Conundrum of Endogenous Retroelements
Kassiotis, G. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101721-033341 · Cited by 90
Metadata
- Authors
- Ambati, J., Magagnoli, J., Leung, H., Wang, S.-B., Andrews, C. A., Fu, D., Pandey, A., Sahu, S., Narendran, S., Hirahara, S., Fukuda, S., Sun, J., Pandya, L., Ambati, M., Pereira, F., Varshney, A., Cummings, T., Hardin, J. W., Edun, B., Bennett, C. L., Ambati, K., Fowler, B. J., Kerur, N., Röver, C., Leitinger, N., Werner, B. C., Stein, J. D., Sutton, S. S., & Gelfand, B. D.
- Affiliations
- University of Virginia Medical Center (US)
- University of South Carolina (US)
- University of Virginia (US)
- University of Michigan (US)
- University of Tsukuba (JP)
- Baystate Medical Center (US)
- University of Kentucky (US)
- Universitätsmedizin Göttingen (DE)
- Corresponding author
- Ambati, Jayakrishna
- ORCID
- Ambati, Jayakrishna
- Magagnoli, Joseph
- Wang, Shao-bin
- Andrews, Chris A.
- Pandey, Akshat
- Sahu, Srabani
- Narendran, Siddharth
- Fukuda, Shinichi
- Sun, Jian
- Ambati, Meenakshi
- Pereira, Felipe
- Varshney, Akhil
- Cummings, Tammy
- Hardin, James W.
- Bennett, Charles L.
- Fowler, Benjamin J.
- Kerur, Nagaraj
- Röver, Christian
- Leitinger, Norbert
- Werner, Brian C.
- Stein, Joshua D.
- Sutton, S. Scott
- Gelfand, Bradley D.
- Venue
- Nature Communications
- Published
- 2020-09-23
- Volume
- 11
- Issue
- 1
- Pages
- 4737-4737
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC7511405
- OpenAlex
- W3089058753
- Cited by
- 66
- References
- 91
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 14 · 2023: 11 · 2022: 3 · 2021: 13
- FWCI
- 0.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Terrestrial Environment Research Center (University of Tsukuba) (submittedVersion, cc-by)
- Funders
- U.S. Department of Health & Human Services | NIH | National Eye Institute (R01EY028027)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- nucleoside reverse transcriptase inhibitors, NLRP3 inflammasome, type 2 diabetes prevention, insulin sensitivity, drug repurposing, lamivudine, HIV-1, hepatitis B, DICER1, insulin resistance, high-fat diet, innate immune signaling
- MeSH terms
- Animals, Cell Survival, Diabetes Mellitus, Type 2, Hepatitis B, Humans, Insulin Resistance, Male, Mice, Inbred C57BL, HIV-1, Adipocytes, Reverse Transcriptase Inhibitors, Muscle Cells, Ribonuclease III, Mice, DEAD-box RNA Helicases, Drug Repositioning, Inflammasomes, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development. https://app.cochat.ai/papers/10.1038/s41467-020-18528-z
- The paper
- Ambati, J., Magagnoli, J., Leung, H., Wang, S.-B., Andrews, C. A., Fu, D., Pandey, A., Sahu, S., Narendran, S., Hirahara, S., Fukuda, S., Sun, J., Pandya, L., Ambati, M., Pereira, F., Varshney, A., Cummings, T., Hardin, J. W., Edun, B., . . . Gelfand, B. D. (2020). Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development. Nature Communications. https://doi.org/10.1038/s41467-020-18528-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.